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bstract
In view of the potential of polymethoxyflavones (PMFs) and hydroxylated PMFs (OH-PMFs) as bioactives against inflammation, we prepared
ix different orange peel extracts (OPEs). The major compounds of these extracts were characterized and quantified by high performance liquid
hromatography (HPLC). Effects on inflammation were analyzed by nutrigenomics using a human cell-based TPA-induced monocyte–macrophage
ifferentiation model employing U-937 cells and inflammatory surrogate genes. Dose response and kinetics analysis of OPEs with different chemical
rofiles revealed less cytotoxic effects of PMFs as compared to OH-PMFs as demonstrated by the MTT-method. Noteworthy, a comparison of two
MF members such as 3,5,6,7,3′,4′-hexamethoxyflavone (HexaMF) and 3,5,6,7,8,3′,4′-heptamethoxyflavone (HeptaMF) exhibited less cytotoxic
ffects of HeptaMF as compared to HexaMF. A specific OPE enriched with HeptaMF, PMFs and OH-PMFs at low concentrations (10 g/mL)
ignificantly down-regulated the expression of a panel of genes involved in inflammatory response, including COX-2, TNF-α, ICAM-1, NFκB, IL-
β, IL-6, and IL-8  with an inflammatory index of −0.55. The strong anti-inflammatory effects were then validated in a mouse carrageenan-induced
aw edema model. Oral intake of OPE reduced paw edema significantly in a dose-dependent manner. Importantly, a dosage of 250 mg/kg gave
n anti-inflammatory effect comparable to ibuprofen. A preliminary clinical study showed that OPE was well tolerated showing no adverse side
ffects. In summary, enrichment of phyto extracts such as OPEs with specific polymethoxyflavones as anti-inflammatory bioactives is a promising
trategy to find naturally derived extracts that are effective against diseases associated with inflammation.
 2014 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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.  Introduction
Chronic inflammation is widely recognized as a major
nderlying cause of various degenerative diseases including
ardiovascular, Alzheimer’s, diabetes, and cancer [1–5]. In
ontrast, acute inflammation is a beneficiary response by
romoting vasodilatation which enables rolling, adhesion, and∗ Corresponding author at: Department of Science, BMCC-City University of
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ndothelial transmigration of leukocytes toward infected tissue.
cute inflammation is initiated by the activation of a variety
f inflammatory genes encoding for adhesion molecules (e.g.
CAM-1, VCAM-1), chemokines (e.g. IL-8), and metabolites
enerated in the arachidonic acid (AA) pathway [1,2,6]. Phos-
holipase A2 provides AA as a substrate for cyclooxygenase-2
COX-2) and 5-lipoxygenase (5-LOX) which generate a variety
f prostaglandins and leukotrienes, respectively, triggering
hemotaxis and vasodilation [1,2,6]. Activation of neutrophils
nables phagocytosis and intracellular degradation of the
ngested material mediated through lysosomal enzymes and
xidative burst. Oxidative burst is characterized by enzymatic
eneration of electrophilic species (ES) such as reactive oxygen
pecies (ROS) and reactive nitrogen species (RNS) generated by
ADPH oxidase, myeloperoxidase and inducible nitric oxide
ynthase (iNOS). Chronic inflammation is characterized by
rolonged duration of persistent infections, immune-mediated
nflammatory diseases, or prolonged exposure to toxic reagents.
onocytes differentiation to macrophages is an important event
n chronic inflammation. Macrophages as the dominant cellular
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layer activate several cytokines (e.g. IFN-γ , TNF-α, IL-1β,
nd IL-12) and chemokines (e.g. IL-8, monocyte chemotactic
rotein-1, and macrophage inflammatory protein-1) to perpet-
ate the inflammatory response [1–3,6,7]. Activation of the
ranscription factor NFB plays a central role in the induction
f many key inflammatory genes such as PLA2, COX-2, iNOS,
CAM-1, IL-1β, IL-6, and IL-8  [2,3,6,7]. The function and inter-
lay of key pro-inflammatory mediators in the inflammation
ascade as well as the balance between their up-regulation and
own-regulation may ultimately determine the degree of inflam-
ation [1,2,8]. It is generally believed that during severe chronic
nflammation, accumulation of tissue destruction caused by ES
oupled with damage induced by proteolytic metalloproteinases
eads to pathological conditions of various diseases including
ardiovascular, Alzheimer’s, diabetes, and cancer [1–5].
The limitation of current anti-inflammatory therapies is
idely acknowledged and evident in the continuous efforts
n the pharmaceutical industry to develop drugs targeting
pecific steps in the inflammatory cascade. Natural prod-
cts have the potential to fill this therapeutic gap addressing
he complexity in the inflammatory cascade thereby reducing
ide effects and compensatory reactions requiring secondary
reatment [8]. Orange peel is rich in flavonoids including
ethylated derivatives such as polymethoxyflavones (PMFs).
MFs have been shown to exhibit strong anti-inflammatory
ffects both at the level of gene expression and enzyme
ctivity [9–16]. In addition, induction of apoptosis by PMFs-
ediated calcium-signaling may attenuate inflammation [17].
lavonoids are typically found throughout the whole fruit
hereas PMFs are found exclusively in the peels of Citrus
enus, particularly in the peels of sweet oranges (Cit-
us sinensis) and mandarin oranges (Citrus  reticulate). As
he most abundant PMFs in orange peel extract (OPE),
angeretin and nobiletin have been demonstrated to have
trong anti-inflammatory effects as indicated by inhibition
f PLA2, COX-2, iNOS, TNF-α, 15-LOX, IL-1β, IL-6, and
ADPH oxidase in different cell-based and animal models
10,12–16,18,19]. Down-regulation of inflammatory genes by
MFs corresponded to suppression of NFB, AP-1, and CREB
18]. Noteworthy, strong anti-inflammatory activities were
ound for 3,5,6,7,8,3′,4′-heptamethoxyflavone [20]. Strong anti-
nflammatory activities were found also for OH-PMFs derived
rom OPE such as 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone,
′
-demethylnobiletin (3′-dNob), 4′-demethylnobiletin (4′-
Nob), and 3′,4′-didemethylnobiletin (3′,4′-dNob) which
ttenuated iNOS, TNF-α, and COX-2  expression [10,15,21–23].
In view of the growing evidence of anti-inflammatory bioac-
ives in orange peel extracts, we have prepared six different OPEs
ontaining different concentrations of PMFs and OH-PMFs.
ffects of different OPEs on cell viability by the MTT-
ethod were evaluated and correlated to different chemical
rofiles. The nutrigenomic method [24,25] was used as measure
or anti-inflammatory bioactivity using a subset of inflam-
atory surrogate genes in a human monocyte–macrophage
ifferentiation model [8]. The OPE enriched with bioac-
ive polymethoxyflavones showed strong anti-inflammatory
ffects as demonstrated in a cell-based human in  vitro
w
w
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onocyte–macrophage differentiation model and a paw edema
n vivo  mouse model.
.  Materials  and  methods
.1.  Materials  and  chemicals
Dulbecco’s modified Eagle’s medium (DMEM) and fetal
ovine serum (FBS) were obtained from Gibco BRL
Gaithersburg, MD). Cell culture flasks, dishes, and 24-well
lates were from Falcon (Becton-Dickinson, Franklin Lakes,
J). For RNA isolation, RNeasyTM Total RNA Kit (Qiagen,
hatsworth, CA) was used. Oligo-dT, dNTPs and SuperscriptTM
I reverse transcriptase were purchased from Invitrogen, Life
echnologies (Grand Island, NY). TaqMan qPCR probes,
rimers and master mix were from Applied Biosystems, Life
echnologies (Grand Island, NY). Other chemicals were pur-
hased from Sigma (St. Louis, MO).
.2.  Preparation  and  analysis  of  orange  peel  extracts
.2.1.  Preparation  of  OPEs
Different batches of sweet orange peel extract (OPE, from
old-pressed orange peel oil) were purchased previously from
lorida Flavors Company (Lakeland, FL). The OPEs were fur-
her purified with a flash chromatography system on a silica
el column to remove majority of essential oils as previous
escribed [26] to obtain OPE with high content of poly-
ethoxyflavones, such as OPE-6 and the precursors of OPE-1 to
PE-5. The obtained OPE precursors were suspended in abso-
ute ethanol and further treated with concentrated hydrochloric
cid for certain period of time monitored with HPLC system
o get the desired content of hydroxylated PMFs. The reac-
ion mixture was then cooled and concentrated in vacuum. The
esidue was dissolved in ethyl acetate and washed with water,
 mol/L sodium bicarbonate, water and brine. The organic layer
as dried over aqueous sodium sulfate, filtered to collect liquid
nd concentrated to remove solvent. The resulting OPEs were
yophilized overnight to get final products (OPE-1 to OPE-5).
As an example, the purchased commercial OPE mixture
10 g) was dissolved in a mixture of methylene chloride (2 mL)
nd hexanes (2 mL) and loaded onto a 120 g pre-conditioned sil-
ca gel flash column. The isocratic solvent was 10% ethyl acetate
nd 90% hexanes and kept eluting for 30 min. Then, another
socratic solvent system with 85% of ethyl acetate and 15% of
exanes was introduced and kept eluting while collecting eluent
s one fraction for another 30 min. OPE (8 g) without essen-
ial oils was obtained. To the obtained OPE 100 mg, 20 mL of
nhydrous ethanol was added and followed by the addition of
 mL concentrated hydrochloric acid. The mixture was heated
o boiling and remained reflux for 16 h. The reaction mixture
as cooled and concentrated in vacuum. The resulted residue
as redissolved in ethyl acetate and washed with water, 1 mol/L
odium bicarbonate solution, water and brine. The organic layer
as separated and dried over anhydrous sodium sulfate. After
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ltration, the filtrate was concentrated in vacuum and lyophilized
or 24 h. Then, 84 mg OPE-5 was obtained.
.2.2. Separation  and  quantiﬁcation  of
olymethoxyﬂavones
The HPLC was equipped with a reversed phase C16 amide
olumn (Ascentis RP-Amide, 150 mm ×  4.6 mm, 3 m), from
upelco (Bellefonte, PA). Gradient elution was used with a
obile phase composed of water (solvent A) and acetonitrile
ACN, solvent B). The optimized condition is as follows: a
0 min gradient was started with 40% B, linearly increased to
5% B in 10 min, then linearly increased to 70% in 15 min, and
nally ramped to 80% in 20 min. Flow rate was 1.0 mL/min
nd the column temperature was maintained at 35 ◦C. Detection
avelength was 326 nm and the injection volume was 10 L.
.3.  Cell  culture  and  treatment
U-937 cells (CRL-1593.2, human histiocytic lymphoma)
ere obtained from the American Type Culture Collection
Rockville, MD). Cells were cultured in RPMI-1640 medium
ith 10% FBS at 37 ◦C in a humidified, 10% CO2 atmosphere.
ells were subcultured in culture flasks (Falcon, Becton-
ickinson, Franklin Lakes, NJ) and passaged every 3 d. Before
xperiments, cells were seeded in 60 mm culture dishes or
4-well plates (Falcon, Becton-Dickinson, Franklin Lakes,
J) as indicated for the different assays. OPEs or PMFs were
pplied directly to the medium to achieve final concentrations
s indicated.
.4.  MTT  cell  proliferation  assay
Cell proliferation was measured by the MTT (3(4,5-
imethylthiazol-2-yl)-2,5-diphenyl-tetrazolium-bromide)
ethod after treatment in 24-well plates for 3 h, 24 h, or 5 d.
he MTT-assay measures mitochondrial activity based on the
onversion of the tetrazolium salt MTT to blue formazan by
itochondrial dehydrogenase activity [27]. Color development
as documented by a scanner (UMAX, Astra 2200) and the
bsorbance was determined spectrophotometrically at 570 nm
sing a multi-well spectrophotometer (Infinite M200, Tecan).
iability is given in percent of the control value (e.g. DMSO
ontrols) and corresponding IC50 values (e.g. 50% of growth
nhibition) are indicated in Section 3. In view of the concern
hat MTT may yield false-positive results for certain cell types
hen treated with flavonoids or polyphenols [28], proliferation
ata were verified by crystal violet dye staining [29].
.5.  Nutrigenomic  analysis
.5.1.  Human  cell-based  model  for  inﬂammation
For analysis of anti-inflammatory potential, we used human
-937 cells as a monocyte–macrophage differentiation model
or nutrigenomic analysis. The expression of a subset of
nflammatory surrogate genes in human monocytes induced
y the inflammatory stimulant 12-O-tetradecanoylphorbol-13-
cetate (TPA) during differentiation to macrophages was used
s measure for anti-inflammatory bioactivity [8,30–32]. For
c
B
“
tuman Wellness 3 (2014) 26–35
utrigenomic analysis, we employed a subset of seven inflam-
atory surrogate genes (COX-2, TNF-α, ICAM-1, NFκB, IL-1β,
L-6, and IL-8) which had been previously selected and validated
hroughout various cell-based, animal and clinical studies by
hole genome Affymetrix microarray, focused Oligo microar-
ay and TaqMan qPCR analysis [8,33,34]. Gene expression
nalysis was performed by RT-PCR and TaqMan qPCR analysis.
.5.2. Reverse  transcription-polymerase  chain  reaction
RT-PCR)
U-937 were treated with TPA (20 nmol/L) either alone or
n combination with OPE (10 g/mL) for 3 h. After treatment
n 60 mm culture dishes, cells were harvested at indicated
imes and the total RNA was prepared using RNeasyTM Total
NA Kit. Then, total RNA (1 g) was reverse transcribed into
DNA by incubating with SuperScriptTM RNase H reverse
ranscriptase using oligo(dT)12–18 as primer. For PCR amplifi-
ation of the human COX-2  gene, gene specific primers, both
ense (5′-TTCAAATGAGATTGTGGGAAAAT-3′) and anti-
ense (5′-AGATCATCTCTGCCTGAGTATCTT-3′) were used.
he expression of the house-keeping gene glyceraldehyde-
-phosphate dehydrogenase (GAPDH) was used as internal
ontrol (sense: 5′-TGAAGCTCGGAGTCAACGGATTTG-3′;
ntisense: 5′-CATGTGGGCCATGAGGTCCACCAC-3′). PCR
onditions were chosen to ensure that the yield of the ampli-
ed products was linear with respect to the amount of input
DNA. PCR products were analyzed by electrophoresis on a
% agarose gel and visualized with ethidium bromide. COX-2
nd GAPDH  expression was quantified by densitometry using
he Image J software (NIH, Bethesda, MD). COX-2  expression
as then normalized to GAPDH  and expressed as the ratio of
he mean experimental channel (TPA + OPE) to the mean control
hannel (TPA alone).
.5.3.  TaqMan  qPCR  analysis
After treatment of U-937 cells with TPA (20 nmol/L) either
lone or in combination with OPE (10 g/mL) for 3 h, total RNA
as isolated using the QIAcube from Qiagen (Chatsworth, CA)
ccording to manufacturer’s protocols. Total RNA was then
everse transcribed using standard protocols and reagents from
nvitrogen, Life Technologies (Grand Island, NY). TaqMan
PCR was run on the Roche 480 Lightcycler for 50 cycles
ith concentrations ranging from 100 ng to 0.01 ng for the
tandard curve. Gene expression of COX-2  (Hs01573471 m1),
NF-α (Hs00174128 m1), ICAM-1  (Hs99999152 m1),
FκB (Hs00153294 m1), IL-1β  (Hs00174097 m1), IL-6
Hs00174131 m1), IL-8  (Hs00174103 m1), and GAPDH
Hs99999905 m1) was analyzed using the probes, primers
nd master mix from Applied Biosystems, Life Technologies
Grand Island, NY; for details see the Assay IDs as indicated
bove in brackets next to the respective genes). After normal-
zation to GAPDH, gene expression was calculated according to
he delta–delta CT method as the ratio of the mean experimental
hannel (TPA + OPE) to the mean control channel (TPA alone).
esides ratios, degree of gene expression was also expressed as
inflammatory index” which was calculated as Log 2 values of
he ratios.
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Fig. 1. Chemical profile of OPE-4. (A) HPLC trace shows a representative chemical profile of OPE-4. HPLC conditions: Supelco Ascentis Amide column,
4.6 mm × 150 mm, 3 m, 100 A; UV 326 nm; mobile phase A, water, mobile phase B, acetonitrile; flow rate, 1 mL/min. Peaks: (1) sinesetin; (2) 3,5,6,7,3′,4′-
hexamethoxyflavone; (3) nobletin; (4) 3,5,7,4′-tetramethoxyflavone; (5) 3,5,6,7,8,3′,4′-heptamethoxyflavone; (6) tangeretin; (7–12) 5-demethylated PMFs. (B)
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structure of 3,5,6,7,3′,4′-hexamethoxyflavone (HexaMF). (C) Structure of 3,5,6
.6.  Mouse  paw  edema  model
The carrageenan-induced mouse hind paw edema model was
sed for determination of anti-inflammatory activity by measur-
ng the degree of edema formation [35]. Male albino mice (6
eeks old) were group housed (6 per cage) and fed standard
ouse chow and tap water ad libitum. All animal experiments
ere approved by the Ethics Committee for Animal Experi-
ents of Rutgers University and were performed in accordance
ith the Guideline for Animal Experiments of the laboratories
protocol no. 87-115). For experiments, mice were grouped in
ve different cohorts and treated by a single oral dose of dif-
erent concentrations of OPE-4 (e.g. 125, 250, and 500 mg/kg)
nd compared to the vehicle control (tocopherol-stripped corn-
il). As positive control we included ibuprofen (100 mg/kg)
emonstrated to have strong anti-inflammatory effects in the
aw edema model in other studies [36]. 1 h after treatment, all
roups received an injection of 0.1 mL of carrageenan (1% in
ater) into the plantar side of the right hind paw of the mice.
he mice were then euthanized 1, 2, 4, and 8 h after carrageenan
njection and hind paws were taken. The degree of swelling was
etermined by paw volume displacement measured by a digi-
al hydroplethysmometer. Results were expressed as area under
he curve (AUC) units or volume of hind paw (mL) at indicated
imes, respectively..7.  Statistics
Results were presented as means ±  standard deviation (SD)
f at least three independent experiments unless otherwise
(
C
P
w′
,4′-heptamethoxyflavone (HeptaMF).
ndicated. Statistical comparisons of data were performed using
tudent’s t-test and analysis of variance (ANOVA).
.  Results
.1.  Preparation  and  characterization  of  different  orange
eel extracts
The commercial sweet orange peel extracts made from cold
ressed oil contain certain amount of essential oil. Intention
as been given to remove the majority of essential oils to
btain the highest content of PMFs and OH-PMFs in the OPEs.
his process was achieved with silica gel flash chromatogra-
hy using 10% of ethyl acetate and 90% of hexanes as eluting
olvents. Other methods or other solvent system may reach the
ame goal of this de-oil process, but the process we used is
t our convenience and non-complexity and it also has high
fficiency in terms of time and cost. The various contents of
H-PMFs in a mixture of OPE was closely monitored in the
rocess of 5-desmethylation of PMFs in OPEs with a validated
PLC method [37]. The control of reaction time is crucial to
btain the desired OH-PMF content in targeted OPE samples.
y following the established procedures of 5-desmethylation of
PE [15] and the monitoring HPLC method [37], we prepared
ix OPE samples ranging from non-desmethylation process
OPE-6) to the maximum 5-desmethylated sample of OPE-5.
oncentrations of individual as well as total PMFs and OH-
MFs were analyzed by HPLC as described in Section 2 and
ere expressed in percent of the individual OPEs (Table 1).
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Fig. 2. Effects of two characterized OPEs on cell viability and COX-2 expression
in U-937 cells. Human monocytes (U-937) were subcultured at 1:20 dilution and
then treated with OPE-1 (A) and OPE-2 (B) at indicated concentrations for 3 h,
24 h, and 5 d as indicated by different symbols (rhombus, square, and triangle),
respectively. The cell growth was monitored by the MTT assay as described in
Section 2. Mean values ± standard deviation of three independent experiments
are shown. (C) Effects of OPE-1 and OPE-2 on TPA-induced COX-2 expression.
U-937 cells were treated by TPA (20 nmol/L) either alone or in combination
with OPE-1 or OPE-2 (50 g/mL) for 3 h. Thereafter, expression of COX-
2 was analyzed by RT-PCR. The expression of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as internal control. COX-2 expression nor-
malized to GAPDH was expressed as the ratio of the mean experimental channel
(
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cTPA + OPE) to the mean control channel (TPA alone) ± standard deviation.
epresentative blots of six independent experiments are shown.
ig. 1 shows the HPLC profile of one of the OPE samples
e.g. OPE-4; A) and the structures of two individual PMFs
uch as 3,5,6,7,3′,4′-hexamethoxyflavone (HexaMF; B) and
,5,6,7,8,3′,4′-heptamethoxyflavone (HeptaMF; C).
.2.  Effects  of  two  characterized  OPEs  on  cell  viability  and
OX-2 expression  in  U-937  cells
For initial screening of effects on cell viability and inflamma-
ion, we chose OPE-1 and OPE-2 which contain similar amount
f total PMFs (around 76%) but differ in OH-PMFs (around 8%
nd 12% for OPE-1 and OPE-2, respectively; Table 1). Fig. 2
hows the effect of these two OPEs on cell viability of human
onocytic U-937 cells. Dose response analysis was performed
n the range from 0.1 to 100 g/mL after 3 h, 24 h, and 5 d of
xposure. For OPE-1, the IC50 values (half-maximal inhibition
f viability) were around 25, 30, and 50 g/mL for 5 d, 24 h, and
 h after exposure, respectively (A). OPE-1 showed slightly less
ytotoxic effects as compared to OPE-2 as indicated by lower
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C50 values after long-term incubation for 5 d (around 8 g/mL)
nd 24 h (around 18 g/mL) for OPE-2 (B). For short-term expo-
ure of 3 h, both OPEs showed IC50 values around 50 g/mL.
nterestingly, higher concentrations of OPE-2 appear to be less
oxic for short-term incubation (3 h) as compared to OPE-1 as
ndicated by a horizontal slope between 50 and 100 g/mL for
PE-1. In view of the concern that MTT may yield false-positive
esults for certain cell types when treated with flavonoids or
olyphenols [28], we verified our proliferation data by the use
f the crystal violet dye assay [29] and achieved similar results
data not shown). Since both OPEs are complex extracts with
imilar concentrations of total PMFs (Table 1), we can only spec-
late whether higher concentrations of OH-PMF in OPE-2 are
esponsible for the differential effects on cell viability.
It is well established that PMF have anti-inflammatory effects
9–16]. Since OPE-1 and OPE-2 both contain high concentra-
ions of PMF (around 75%), we were interested in the effects of
oth OPEs on inflammation. For initial nutrigenomic screening,
e chose cyclooxygenase-2 (COX-2) as inflammatory gene.
OX-2 has become an important pharmacological target for
nflammatory diseases [38,39] and previous studies indicated
 suppression of TPA-induced COX-2  expression in cell-based
nd animal studies by PMFs [12,15,16,18,19,23]. To examine
he effects of OPE-1 and OP-2 on COX-2  expression, we per-
ormed RT-PCR analysis in U-937 cells. Cells were treated with
PA (20 nmol/L) either alone or in combination with OPE-1
nd OPE-2 (50 g/mL) for 3 h. Glyceraldehyde-3-phosphate
ehydrogenase (GAPDH) was used as internal control. Fig. 2C
hows the expression of COX-2  at the mRNA level as the ratio
f the mean experimental channel (TPA + OPE) to the mean
ontrol channel (TPA alone) normalized to GAPDH. Although
oth OPEs were applied at high concentrations (e.g. 50 g/mL)
hich are in the range of IC50 values (Fig. 2A and B), inhibitory
ffects on gene transcription are less likely as indicated by
nchanged GAPDH  expression in response to both OPEs. We
bserved a dramatic decrease of TPA-induced COX-2  expression
n response to both OPE-1 and OPE-2 (P  < 0.001). For OPE-1,
here appears to be slight stronger anti-inflammatory effects as
ompared to OPE-2 as indicated by ratios of 0.18 and 0.22,
espectively, although the differences between OPE-1 and -2
ere not statistically significant.
.3.  Comparison  of  the  effects  of  different  OPEs  and  Hexa-
nd HeptaMF  on  viability  of  U-937  cells
Our analysis of OPE-1 and OPE-2 showed a similar chemical
rofile for PMFs and slight differences for OH-PMFs (Table 1).
ell viability analysis showed slight differences between OPE-1
nd -2 by comparing long-term and short-term kinetics which
ight be correlated to the slight differences in OH-PMF content
see Section 3.2). We were now interested in the effects of other
PEs (OPE-3–OPE-6) containing different concentrations of
MFs and OH-PMFs (Table 1). As described in Section 3.2, we
sed the MTT cell proliferation assay for kinetic analysis of the
ifferent OPEs after 3 h, 24 h, and 5 d of exposure with a dose
esponse analysis in the range from 0.1 to 100 g/mL. OPE-3
Fig. 3A) and OPE-4 (Fig. 3B) showed similar effects on cell
c
c
m
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iability as indicated by corresponding IC50 values around 7,
2, and 50 g/mL for OPE-3 or around 8, 15, and 50 g/mL
or OPE-4 after long-term exposures for 5 d, 24 h, and 3 h,
espectively. OPE-5 (Fig. 3C) showed more cytotoxic effects
s indicated by lower IC50 values around 5 and 7 g/mL for
ong-term kinetics after 5 d and 24 h, respectively. An incuba-
ion of 10 g/mL for 5 d was lethal to all of the cells. On the other
and, an IC50 value around 50 g/mL after 3 h of exposure was
imilar to that of OPE-3 and OPE-4. As compared to the other
PEs, OPE-6 (Fig. 3D) was prominently less cytotoxic after
ong term incubation for 5 d and 24 h showing IC50 values around
5 and 30 g/mL, whereas the IC50 value around 70 g/mL
fter 3 h was similar to that of OPE-3 (A) and OPE-4 (B). Our
hemical profiling (Table 1) revealed that all of the orange peel
xtracts (with the exception of OPE-5) contain the two individ-
al PMFs, 3,5,6,7,3′,4′-hexamethoxyflavone (HexaMF, Fig. 1B)
nd 3,5,6,7,8,3′,4′-heptamethoxyflavone (HeptaMF, Fig. 1C),
atter reported to play a role as anti-inflammatory bioactive [20].
We were now interested in the effects of Hexa- and HeptaMF
n cell viability. HexaMF showed IC50 values around 25, 30, and
00 mol/L after 5 d, 24 h, and 3 h of incubation, respectively
Fig. 3E). Interestingly, we observed less cytotoxic effects of
eptaMF (Fig. 3F) as compared to HexaMF for long-time incu-
ation showing IC50 values around 140 and 190 mol/L for 5 d
nd 24 h incubation, respectively. On the other hand, short-term
xposure (3 h) showed similar effects on cell viability of Hep-
aMF as well as HexaMF (e.g. IC50 value around 500 mol/L). In
ummary, we observed less cytotoxic effects of OPEs containing
igher amounts of total PMFs after long-term exposure for 5 d
nd 24 h. On the other hand, OH-PMFs appeared to have slightly
tronger cytotoxic effects as indicated by OPE with increasing
oncentration of OH-PMFs (e.g. OPE-5 containing around 53%
f total OH-PMFs) showing lower IC50 values after long-term
xposure. This is in line with our observation that OPE-2 (around
2% OH-PMFs) exhibited lower IC50 values after 5 d (8 g/mL)
nd 24 h (18 g/mL) as compared to OPE-1 (around 8% OH-
MFs) showing IC50 values around 25 and 30 g/mL after 5 d
nd 24 h, respectively (see Section 3.2).
.4.  Effects  of  OPE-4  on  expression  of  inﬂammatory  genes
n U-937  cells
For further analysis of effects against inflammation we chose
PE-4 for several reasons: OPE-4 containing high amounts
f HeptaMF (around 14%) was reported to have strong anti-
nflammatory activity [20]. In addition, our viability analysis
howed less cytotoxic effects of HeptaMF as compared to Hex-
MF (see Section 3.3). Most importantly, OPE-4 contains high
mounts of PMFs (52%) and OH-PMFs (21%) both reported
o have strong anti-inflammatory effects [10,12–16,21–23]. For
xperiments, we used the U-937 cell model for inflammation
mploying a subset of seven inflammatory surrogate genes
COX-2, TNF-α, ICAM-1, NFκB, IL-1β, IL-6, and IL-8). U-937
ells were treated for 3 h with TPA (20 nmol/L) either alone or in
ombination with OPE-4 (10 g/mL), a concentration showing
ore than 90% cell viability using the MTT-method (Fig. 3B).
ene expression of COX-2, TNF-α, ICAM-1, NFκB, IL-1β, IL-6,
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Fig. 3. Comparison of the effects of different OPEs and Hexa- and HeptaMF on viability of U-937 cells. Human monocytes (U-937) were subcultured at 1:20 dilution
and then treated with different OPEs, HexaMF, and HeptaMF at indicated concentrations for 3 h, 24 h, and 5 d as indicated by different symbols (rhombus, square,
and triangle), respectively. The cell growth was monitored by the MTT assay as described in Section 2. Mean values ± standard deviation of three independent
experiments are shown. (A) OPE-3; (B) OPE-4; (C) OPE-5; (D) OPE-6; (E) 3,5,6,7,3′,4′-hexamethoxyflavone (HexaMF); (F) 3,5,6,7,8,3′,4′-heptamethoxyflavone
(HeptaMF).
Fig. 4. Effects of OPE-4 on expression of inflammatory genes in U-937 cells. Human monocytes (U-937) were treated by TPA (20 nmol/L) either alone or in
combination with OPE-4 (10 g/mL) for 3 h. After RNA isolation and reverse transcription, expression of either (A) COX-2, (B) TNF-α, or (C) a subset of seven
inflammatory surrogate genes (COX-2, TNF-α, ICAM-1, NFκB, IL-1β, IL-6, and IL-8) was analyzed by TaqMan qPCR and normalized to GAPDH. Gene expression
is shown as the ratio of the mean experimental channel (TPA + OPE-4) to the mean control channel (TPA alone) or expressed as “inflammatory index” calculated
as Log 2 values of the ratio. Ratios below 1 or inflammatory indices below 0 suggest anti-inflammatory activity as indicated by an inhibition of the expression of
inflammatory genes. COX-2 (A) and TNF-α (B) ratios (left columns) and inflammatory indices (right columns) are shown. (C) Inflammatory indices of seven genes
(
i
COX-2, TNF-α, ICAM-1, NFκB, IL-1β, IL-6, and IL-8) are shown. For OPE-4 an i
ndicates significant differences from the control group with P < 0.05 as analyzed by nflammatory index of −0.55 by integrating all seven genes was calculated. *
ANOVA.
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Fig. 5. Effects of OPE-4 on carrageenan-induced paw edema in mice. Mice received a single oral dose of control vehicle (tocopherol-stripped corn-oil), different
concentrations of OPE-4 (e.g. 125, 250, and 500 mg/kg), or ibuprofen (100 mg/kg), respectively. 1 h after treatment, all groups received an injection of 0.1 mL of
carrageenan (1% in water) into the plantar side of the right hind paw. The mice were then euthanized 1, 2, 4, and 8 h after carrageenan injection. The degree of
swelling was determined by paw volume displacement measured at indicated times by a digital hydroplethysmometer. Results are expressed as the mean ± SD area
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lnder the curve (AUC) units after 8 h (A) or volume of hind paw/mL for diffe
ontrol group with P < 0.05 and 0.01, respectively as analyzed by ANOVA.
nd IL-8  was analyzed by TaqMan qPCR analysis and normal-
zed to GAPDH. Gene expression is shown as the ratio of the
ean experimental channel (TPA + OPE-4) to the mean con-
rol channel (TPA alone) or expressed as “inflammatory index”
alculated as Log 2 values of the ratio as described in Section
. OPE-4 showed strong anti-inflammatory effects (Fig. 4C)
s indicated by an inflammatory index of −0.55 by integrat-
ng all seven genes (COX-2, TNF-α, ICAM-1, NFκB, IL-1β,
L-6, and IL-8). Noteworthy, all seven genes showed a down-
egulation in response to OPE-4 as compared to the TPA control
s indicated by negative inflammatory indices. In another set
f experiments we validated our results of a down-regulation
f COX-2  and TNF-α, two important genes in the inflamma-
ory cascade [1,2,4,5,8]. Expression of COX-2  (Fig. 4A) and
NF-α (Fig. 4B) was expressed as ratios (left columns) as well
s inflammatory indices (right columns). Treatment with OPE-
 (10 g/mL) induced a significant down-regulation of COX-2
nd TNF-α  (both P  < 0.05) as indicated by low ratios of 0.61
nd 0.45 which corresponded to inflammatory indices of −0.72
nd −1.16 for COX-2  and TNF-α, respectively. In summary, we
bserved a strong anti-inflammatory potential of OPE-4 as indi-
ated by significant down-regulation of TPA-induced expression
f inflammatory surrogate genes.
.5.  Effects  of  OPE-4  on  carrageenan-induced  paw  edema
n mice
Using a carrageenan-induced paw edema model, we
nvestigated the effects of OPE-4 which showed strong anti-
nflammatory potential as indicated by strong down-regulation
f inflammatory surrogate genes as demonstrated in our
ell-based model for inflammation (see Section 3.4). For
xperiments, mice were treated by different concentrations
f OPE-4 and compared to the vehicle control. As positive
ontrol, we included ibuprofen demonstrated to have strong anti-
nflammatory effects in the paw edema model in other studies
36]. As shown in Fig. 5A we observed a reduction of paw
f
r
[
rme points (B), respectively. * and ** indicate significant differences from the
dema in a dose-dependent manner by OPE-4 as compared to the
arrageen-treated control group 8 h after carrageenan injection.
ignificant effects of paw edema inhibition by OPE-4 started
t 250 mg/kg (P  < 0.05) and increased in response to a higher
osage of 500 mg/kg (P  < 0.01). Importantly, OPE-4 at a dosage
f 250 mg/kg showed anti-inflammatory effects comparable to
buprofen (100 mg/kg). Kinetic analysis (Fig. 5B) showed sig-
ificant effects at high dosages of OPE-4 (500 mg/kg) as soon
s 4 h after carrageenan injection (P  < 0.05). In summary, we
bserved a significant reduction of carrageenan-induced paw
dema formation in a dose-dependent manner. Noteworthy,
osages around 250 mg/kg showed anti-inflammatory effects
omparable to ibuprofen. Strong anti-inflammatory effects of
PE-4 correlated to nutrigenomic screening analysis (see Sec-
ion 3.4) showing a strong down-regulation of TPA-induced
nflammatory surrogate genes as obtained in our cell-based
odel for inflammation.
.  Discussion
In this study, we prepared six different orange peel extracts
nd quantified major compounds by HPLC. By comparing the
ifferent OPEs, we looked for relationships between chemical
rofiles and cell viability profiles. Our analysis revealed cytopro-
ective effects of PMFs as indicated by an increase of IC50 values
or OPEs with increasing amounts of total PMFs after long-term
xposure for 5 d and 24 h. On the other hand, OH-PMFs appear
o have cytotoxic effects as indicated by a decrease of IC50 val-
es for OPE with increasing concentration of OH-PMFs. OPE-5
ontaining the highest amount of total OH-PMFs (around 53%)
howed the lowest IC50 value after long-term exposures of 24 h
nd 5 d. Since OPEs are complex extracts, we can only specu-
ate whether higher concentrations of OH-PMF are responsible
or the differential effects on cell viability. But our results cor-
elate to pro-apoptotic effects of OH-PMFs as observed earlier
17,40]. Despite of potential cytotoxic effects, OH-PMFs are
eported to be strong agents against inflammation [10,15,21–23].
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o gain insights in possible structure-activity relationships,
e compared effects on cell viability by 3,5,6,7,3′,4′-
examethoxyflavone and 3,5,6,7,8,3′,4′-heptamethoxyflavone.
ntriguingly, HeptaMF showed less cytotoxic effects as com-
ared to HexaMF. Previously, it has been reported that HeptaMF
ave strong anti-inflammatory activity [20]. In the light of Hep-
aMF, PMFs and OH-PMFs as anti-inflammatory bioactives, we
elected OPE-4 for further evaluation of its anti-inflammatory
ffects since it contains high amounts of cytoprotective Hep-
aMF (14%), PMFs (52%) and OH-PMFs (21%) reported to
ave strong anti-inflammatory effects in cell-based in  vivo  and
nimal in  vivo  models [10,12–16,18–23].
Anti-inflammatory potential of OPE-4 was evaluated by the
utrigenomic method [24,25]. In the past two decades, differ-
nt cell-based and animal models have been used to analyze the
ffects of test extracts on expression of genes related to a vari-
ty of diseases, a discipline called nutrigenomics [24,25]. In our
uman cell-based model for inflammation, we used the phor-
ol ester TPA to induce differentiation of the human monocytic
ell line (U-937) to macrophages [31,32,41]. During differen-
iation, a variety of inflammatory genes that are up-regulated
lay key roles in the inflammatory cascade and are relevant
n chronic inflammatory diseases [1,2,4,5,8]. Previously, we
ave selected a subset of seven inflammatory surrogate genes
or nutrigenomic screening (COX-2, TNF-α, ICAM-1, NFκB,
L-1β, IL-6, and IL-8) which have been validated throughout
arious cell-based, animal and clinical studies by whole genome
ffymetrix microarray, focused Oligo microarray and TaqMan
PCR analysis [8,33,34]. Our present study revealed strong anti-
nflammatory effects of OPE-4 as indicated by a TPA-induced
own-regulation of COX-2, TNF-α, ICAM-1, NFκB, IL-1β, IL-6,
nd IL-8  in our cell-based human model for inflammation. Inter-
stingly, we observed an attenuation of the p65 subunit of NFκB
n our gene expression analysis. Our non-significant effects
orrelate to high constitutive expression levels of p65  [7]. Inter-
stingly, a posttranslational inhibition of NFκB  through blocking
f IκB  was observed by PMFs [18,21,22]. Activation of NFκB
lays a central role to initiate and promote the inflammatory
esponse through induction of many key inflammatory genes.
herefore, NFκB  has been in the focus of anti-inflammatory ther-
py [1–3,7,42,43]. In addition to our nutrigenomic analysis, we
sed the paw edema mouse model to evaluate anti-inflammatory
ioactivity of OPE-4. The carrageenan-induced mouse paw
dema model has been used for decades as a reliable model
or studying the mechanisms acute and chronic inflammation
35]. Strong anti-inflammatory effects of OPE-4 were confirmed
n the in  vivo  paw edema mouse model showing a significant
ose-dependent attenuation of edema. Importantly, effects at
50 mg/kg were comparable to the effects of ibuprofen, a well
stablished drug against inflammation shown to inhibit paw
dema [36].
Previously, we proposed a chemical characterization of nat-
ral extracts to be essential to insure adequate consistency in
erformance [8]. Our data showed that an enrichment of orange
eel extracts with specific polymethoxyflavones is a promis-
ng strategy to find natural-derived extracts effective against
nflammation. Although the techniques in characterization of
[uman Wellness 3 (2014) 26–35
atural extracts are advancing, still a complete characteriza-
ion of natural extracts is difficult. Complex natural extracts
uch as OPEs are rich in polymethoxyflavones and hydroxylated
olymethoxyflavones. These bioactives may have potential syn-
rgistic effects but other unknown components may also have
dditive, even synergistic positive or negative effects which may
ccount for its efficacy and effectiveness against inflammation.
n another study, strong anti-inflammatory effects were observed
or a citrus peel extract enriched with PMFs which correlated
o inhibition of tumorigenesis [9]. Previously, we found that
MF-enriched OPE was well tolerated in humans and showed
o adverse reactions in a small colon cancer pilot study (data not
hown). Thus, the overall content and formulation of this specific
range peel product presents a unique chemical profile lead-
ng to strong anti-inflammation activity in our tested cell-based
n vitro  and mouse paw edema in  vivo  model which qualifies
s promising candidate extract against diseases associated with
nflammation.
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